基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 生化试剂 激动剂抑制剂 CCT245737 CCT245737
  • aladdin 阿拉丁 C413955 CCT245737 1489389-18-5 99%

aladdin 阿拉丁 C413955 CCT245737 1489389-18-5 99%

CCT245737
1489389-18-5
758.90 5mg 起订
2319.90 25mg 起订
5940.90 100mg 起订
上海 更新日期:2025-11-14

上海阿拉丁生化科技股份有限公司

VIP14年
联系人:阿拉丁客服
电话:400-6206333拨打
手机:13167063860 拨打
邮箱:anhua.mao@aladdin-e.com

产品详情:

中文名称:
CCT245737
英文名称:
CCT245737
CAS号:
1489389-18-5
品牌:
阿拉丁
产地:
上海
保存条件:
-20°C储存
纯度规格:
Moligand™, ≥99%
产品类别:
小分子和化合物库 配体家族
分子式:
C16H16F3N7O
分子量:
379.34
运输条件:
超低温运输
产品规格:
25mg、5mg、100mg
货号:
C413955
是否进口:

中文名:CCT245737

英文名:CCT245737

纯度:Moligand™,≥99%

货号:C413955

Cas号:1489389-18-5

存储温度:-20°C储存

运输条件:超低温运输

产品介绍:

Information

CCT245737 (SRA737, PNT-737) is an orally activeCHK1inhibitor with The IC50 of 1.4 nM. It exhibits >1,000-fold selectivity against CHK2 and CDK1.


Targets

Chk1 (Cell-free assay) 1.4 nM


In vitro

CCT245737 is a potent inhibitor of recombinant human CHK1 with IC50 of 1.4±0.3 nM (mean±SD, n = 3, EZ Reader II assay). There is > 1,000-fold selectivity for CHK1 versus the functionally important kinases CDK1 and CHK2 (IC50=1.26-2.44 and 9.03 μM, respectively), and at least a 90-fold selectivity against cross-reacting kinases such as ERK8, PKD1, RSK1 and 2. CCT245737 potently inhibits cellular CHK1 activity (IC50 30-220nM) and enhances gemcitabine and SN38 cytotoxicity in multiple human tumor cell lines and human tumor xenograft models. It can abrogate an etoposide-induced G2/M arrest. CCT245737 has high cell permeability, as measured by transport across a CaCo2 cell monolayer.


In vivo

Mouse oral bioavailability is complete (100%) with extensive tumor exposure. CCT245737 shows significant single-agent activity against a MYC-driven mouse model of B-cell lymphoma. An i.v. dose of 10mg/kg CCT245737 into BALB/c mice gives a peak plasma concentration of 4μmol/L, with a half-life of 2.86h, an AUC0-∞ of 9.96μmol.h/L, a plasma clearance of 2.1L/h/kg and a large volume of distribution (0.19L). The equivalent oral dose gave an almost identical profile with an AUC0-∞ of 10.4μmol.h/L showing complete oral bioavailability (F = 105%). In a word, CCT245737 shows complete oral bioavailability with linear pharmacokinetics and high tumor/plasma ratios consistent with extensive tumor exposure. Adequate CCT245737 tumor drug exposure takes a significant antitumor activity.


Cell Research(from reference)

Cell lines:The colon tumor cell lines HT29 and SW620, the pancreatic cancer cell line MiaPaCa-2 and the non-small cell lung cancer Calu6 cell line 

Incubation Time:96 h 


查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/C413955.html


(R)-5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile ; (R)5-((4-((Morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile ; 2-Pyrazinecarbonitrile, 5-((4-(((2R)-2-morpholin

公司简介

上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。 阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内(www.aladdin-e.com)和海外(www.aladdinsci.com)电商平台。

成立日期 (17年)
注册资本 10093.34万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 生物化工,生物化工,化学试剂,化学试剂

CCT245737相关厂家报价

  • CCT245737
  • CCT245737
  • 汇聚化学(上海)有限公司
  • 2022-02-24
  • 询价
内容声明
拨打电话 立即询价